Prevention of Liver Fibrosis and Cancer in Africa. Observational Study of Screening, Assessment and Treatment for Chronic Hepatitis B Virus Infection
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2019
Price : $35 *
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatic fibrosis; Hepatitis B; Liver cancer
- Focus Therapeutic Use
- Acronyms PROLIFICA; WATCH
- 08 Oct 2019 Planned End Date changed from 1 Dec 2016 to 1 Apr 2020.
- 08 Oct 2019 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2020.
- 08 Oct 2019 Status changed from completed to active, no longer recruiting.